Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: a subset analysis of two phase 3 randomized trials in plaque psoriasis
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Supplemental material for Original Article titled "Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: a subset analysis of two phase 3 randomized trials in plaque psoriasis".
原创研究论文《氘可来昔替尼（Deucravacitinib）：一种选择性别构酪氨酸激酶2（tyrosine kinase 2）抑制剂治疗头皮银屑病——两项斑块状银屑病3期随机临床试验的亚组分析》的补充材料
创建时间：
2023-12-12
